Catalyst Pharmaceuticals appoints Tamar Thompson to its board of directors

Catalyst Pharmaceuticals, Inc. CORAL GABLES, Fla., May 30, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (\”Catalyst\” or Company) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on the licensing, development and commercialization of new drugs for rare disease patients, today announced the appointment of Ms. Tamar Thompson to the Company\’s Board of Directors (\”Board\”), effective May … Read more